The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (17.68) USD. With the latest stock price at 7.00 USD, the upside of Exagen Inc based on DCF is -352.6%.
Based on the latest price of 7.00 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 352.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.5% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (84.66) - (10.45) | (17.68) |
| Upside | -1309.4% - -249.3% | -352.6% |